July 29th 2019, 6:05pm
The merging of MyLifeLine.org with Cancer Support Community facilitates more comprehensive social and emotional support for patients and caregivers affected by cancer.
July 24th 2019, 1:00am
Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.
July 23rd 2019, 7:00pm
Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.
July 23rd 2019, 12:00am
Patients with breast cancer can still enroll in a clinical trial that is seeking to find the cause behind cardiac toxicity related to anthracycline-based treatment.
July 17th 2019, 8:32pm
With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.
July 15th 2019, 10:05pm
With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.
July 15th 2019, 6:42pm
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
July 15th 2019, 5:20pm
A breast cancer survivor and hereditary cancer expert discussed how patients can find accurate information about genetic mutations.
July 10th 2019, 6:05pm
One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.
July 9th 2019, 5:00pm
While half of women with gynecologic cancer reported experiencing significant fatigue during treatment, only 8% of survivors had symptoms regress without intervention.
July 9th 2019, 12:00am
Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.
July 8th 2019, 4:47pm
A glioblastoma (GBM)-specific app, called OurBrainBank, efficiently collected patients’ symptoms – offering many hope for future research, according to founder Jessica Morris.
July 5th 2019, 5:00pm
Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.
July 4th 2019, 5:00pm
A lymphoma expert discusses the side effect profile and follow-up data from the ECHELON-1 clinical trial.
July 3rd 2019, 9:00pm
Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.
July 1st 2019, 7:00pm
Breakthroughs such as CAR-T cell therapy in the treatment of mantle cell lymphoma could help patients overcome drug resistance and ultimately live longer, according to Dr. Michael Wang.
June 28th 2019, 4:00pm
Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.
June 27th 2019, 7:50pm
Newer treatments for MCL offer hope to patients living with the fast-growing and challenging-to-treat disease.
June 26th 2019, 8:00pm
Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.
June 25th 2019, 10:00pm
The president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association discussed new initiatives and what’s on the horizon in the treatment of liver cancer.
June 24th 2019, 10:56pm
In assessing the quality of family cancer history entered into electronic health records, researchers found that such reporting was suboptimal – highlighting the need to optimize online collection with a provider-free approach.
June 24th 2019, 8:00pm
Increased tumor mutation burden (TMB), which is associated with more inflammation, may be a factor in determining which patients with lung cancer are at higher risk for depression.
June 21st 2019, 5:24pm
The growing use of immunotherapy in oncology has confronted many community practice-based oncologists with challenges to implementation, but one advocacy group’s new initiative aims to educate and empower.
June 19th 2019, 8:21pm
The financial navigation program at Taussig Cancer Institute provides patient assistance and helps them understand out-of-pocket costs.
June 19th 2019, 7:24pm
Although palliative care has been shown to improve survival rates among patients with metastatic renal cell carcinoma, its utilization remains low while certain barriers and disparities still exist.
June 14th 2019, 5:00pm
With so many cancer treatment options now available, clinicians may still fall short in understanding what’s important to patients.
June 13th 2019, 5:00pm
Maintenance therapy with Imbruvica appeared to be a feasible option for patients with mantle cell lymphoma, according to Dr. Reem Karmali.